540
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Blood coagulation: a powerful bactericidal mechanism of human innate immunity

&
Pages 3-17 | Received 06 Jun 2018, Accepted 30 Sep 2018, Published online: 11 Jan 2019
 

Abstract

Infection proliferates and disseminates rapidly and so innate immunity should react effectively and fast. Innate immunity mechanisms depend upon fluid dynamics and are different in compartments with slow (the tissues) and rapid (the bloodstream) liquid flow. In the tissues, coagulation initiated by clotting factors, platelets and erythrocytes, is prompt and effective mechanism of the first line of antibacterial defense. Resident macrophages, transmigrated neutrophils, monocytes, NETs and platelets are the second line of the defense. In the bloodstream the first line of innate immunity defense are erythrocytes that kill pathogens by oxygen, released from oxyhemoglobin (oxycytosis); the second line of the defense is coagulation that in case of overactivation may cause disseminated intravascular coagulation (DIC). Blood coagulation is the fastest mechanism of infection confinement and inactivation. It is the first and the last line of innate immunity defense and occurs both in the tissues and the bloodstream.

Disclosure statement

The authors report no conflict of interest. The authors alone are responsible for the content and writing the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.